Apini Therapeutics
PrivateLast Round
Seed
Jun 11, 2025
Company Overview
Apini Therapeutics is a biotechnology company that develops small molecule compounds for the treatment of chronic inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apini Therapeutics Comparables
Compare Apini Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensho Therapeutics | 81% | |
| Micromune Therapeutics | 80% | |
| Cibus Therapeutics | 79% |
Apini Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 11, 2025 | ||||
| Accelerator | Nov 14, 2024 |
Apini Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Seed, Accelerator |
| Northern Gritstone | Seed |
| The University of Manchester Innovation Factory | Accelerator |
Apini Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Apini Therapeutics's valuation, stock price, and market status.
Is Apini Therapeutics a public or private company?
Apini Therapeutics is a private company.
What is the current stock price of Apini Therapeutics?
Apini Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Apini Therapeutics worth (valuation)?
Valuation information for Apini Therapeutics is not publicly available.
Can I buy Apini Therapeutics stock?
Apini Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Apini Therapeutics's last funding round?
Apini Therapeutics's most recent funding round was Seed on June 11, 2025.
Who are the main investors in Apini Therapeutics?
Key investors in Apini Therapeutics include Syncona, Northern Gritstone.
Will Apini Therapeutics IPO soon?
No public IPO plans have been announced for Apini Therapeutics.
How can I track Apini Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Apini Therapeutics's secondary market activity and sign up for updates.